The World Health Organization (WHO) reports that more than 22% of the world's population smokes, leading to over 9 million deaths each year due to...
Vous n'êtes pas connecté
Procyclidine shows promise in reducing nicotine withdrawal symptoms, providing a potential new option for smoking cessation therapy.
The World Health Organization (WHO) reports that more than 22% of the world's population smokes, leading to over 9 million deaths each year due to...
PHOENIXVILLE, Pa., Feb. 13, 2025 /PRNewswire/ -- PleoPharma, Inc., a privately held company focused on finding treatments for cannabis related health...
Wed, Feb 12, 2025 -- The FDA has granted Fast Track Designation to Lundbeck’s investigational drug, amlenetug, a potential new treatment option...
The U.S. Food and Drug Administration (FDA) has approved Onapgo (apomorphine hydrochloride) injection, the first and only wearable subcutaneous...
A combination of mRNA and a new lipid nanoparticle could help heal damaged lungs, according to new research from the Perelman School of Medicine at...
Backers of a new livestock feed additive say its breakthrough key ingredient provides a low-cost solution for reducing methane emissions from cattle.
Dravet syndrome and other developmental epileptic encephalopathies are rare but devastating conditions that cause a host of symptoms in children,...
Repurposing amlodipine, a commonly used blood pressure medicine, could help manage attention-deficit/ hyperactivity disorder (ADHD) symptoms,...
The effectiveness of a common drug to quit smoking could be down to people's genes, according to a study from the University of Leicester (United...
TUESDAY, Feb. 18, 2025 -- The U.S. Food and Drug Administration has approved a new drug application for a tablet version of Evrysdi (risdiplam) for...